AIRLINK 189.36 Increased By ▲ 1.33 (0.71%)
BOP 11.10 Decreased By ▼ -0.76 (-6.41%)
CNERGY 7.28 Decreased By ▼ -0.26 (-3.45%)
FCCL 36.65 Decreased By ▼ -1.14 (-3.02%)
FFL 14.95 Decreased By ▼ -0.29 (-1.9%)
FLYNG 26.19 Increased By ▲ 0.66 (2.59%)
HUBC 130.89 Increased By ▲ 0.74 (0.57%)
HUMNL 13.47 Decreased By ▼ -0.14 (-1.03%)
KEL 4.28 Decreased By ▼ -0.07 (-1.61%)
KOSM 6.08 Decreased By ▼ -0.09 (-1.46%)
MLCF 45.94 Increased By ▲ 0.26 (0.57%)
OGDC 201.86 Decreased By ▼ -4.57 (-2.21%)
PACE 6.12 Decreased By ▼ -0.26 (-4.08%)
PAEL 38.36 Decreased By ▼ -1.95 (-4.84%)
PIAHCLA 16.73 Decreased By ▼ -0.22 (-1.3%)
PIBTL 7.94 Decreased By ▼ -0.09 (-1.12%)
POWER 9.86 Decreased By ▼ -0.17 (-1.69%)
PPL 173.46 Decreased By ▼ -5.38 (-3.01%)
PRL 34.73 Decreased By ▼ -1.63 (-4.48%)
PTC 23.95 Decreased By ▼ -0.44 (-1.8%)
SEARL 101.74 Decreased By ▼ -1.42 (-1.38%)
SILK 1.07 No Change ▼ 0.00 (0%)
SSGC 32.70 Decreased By ▼ -3.54 (-9.77%)
SYM 17.93 Decreased By ▼ -0.30 (-1.65%)
TELE 8.14 Decreased By ▼ -0.24 (-2.86%)
TPLP 12.02 Decreased By ▼ -0.14 (-1.15%)
TRG 67.40 Increased By ▲ 0.07 (0.1%)
WAVESAPP 11.80 Decreased By ▼ -0.21 (-1.75%)
WTL 1.52 Decreased By ▼ -0.05 (-3.18%)
YOUW 3.90 Increased By ▲ 0.01 (0.26%)
BR100 11,819 Decreased By -87.9 (-0.74%)
BR30 35,000 Decreased By -554.1 (-1.56%)
KSE100 112,085 Decreased By -478.8 (-0.43%)
KSE30 34,946 Decreased By -148 (-0.42%)

clinical trials

Valneva's COVID-19 shot set for Phase Three trial this month
World

Valneva's COVID-19 shot set for Phase Three trial this month

  • The vaccine, Valneva said, was "generally safe and well tolerated across all dose groups tested, with no safety concerns identified by an independent Data Safety Monitoring Board".
  • "Based on the data assessed, the company has decided to advance the high dose into the phase 3 clinical trial. Other trials, including booster trials, involving antigen sparing doses will also be evaluated," Valneva said.
Updated 06 Apr, 2021 07:29pm
COVID-19: Govt's plan to procure vaccine is insufficient to protect country's 220 million population
Pakistan

COVID-19: Govt's plan to procure vaccine is insufficient to protect country's 220 million population

  • Pakistan is still waiting for the United Nation’s Covax mechanism to receive around 45 million free vaccine doses that will cover country’s 20 percent population
  • Many states including Turkey, Columbia, Bangladesh, Malaysia and India have already struck deals with different COVID-19 vaccine manufacturing firms
  • The Pakistan government has allowed the private sector players to procure vaccine from anywhere in the world and get registered with DRAP
Published 11 Jan, 2021 01:24pm
Sindh Health Secretary gets COVID-19 vaccine shot in clinical trials
Pakistan

Sindh Health Secretary gets COVID-19 vaccine shot in clinical trials

  • “I have presented myself for the vaccine trial as secretary health,” says Dr Kazim Jatoi.
  • Several prominent public figures including Punjab Governor Chaudhry Sarwar and his wife have volunteered to be vaccinated in clinical trials of a Chinese vaccine being conducted in the country.
Published 31 Dec, 2020 03:04pm